No. I don't blame Lederle for not solving the issue as the approach we used did not exist back in the 1980s. There have been huge advances in drug formulation over the last 40 years.
- Forums
- ASX - By Stock
- RAC
- Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-42
-
-
- There are more pages in this discussion • 350 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.59 |
Change
0.000(0.00%) |
Mkt cap ! $270.9M |
Open | High | Low | Value | Volume |
$1.61 | $1.62 | $1.55 | $189.9K | 121.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1316 | $1.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.59 | 34961 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1316 | 1.580 |
1 | 400 | 1.560 |
2 | 8157 | 1.550 |
1 | 6250 | 1.540 |
1 | 25000 | 1.530 |
Price($) | Vol. | No. |
---|---|---|
1.590 | 34961 | 1 |
1.595 | 3134 | 2 |
1.600 | 3000 | 1 |
1.650 | 17029 | 2 |
1.690 | 6570 | 3 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online